Your browser doesn't support javascript.
loading
Comparison of Therapeutic Efficacy and Safety between Chlorquinaldol-promestriene and Miconazole Nitrate for Simple Vulvovaginal Candidiasis / 中国药房
China Pharmacy ; (12): 3791-3793, 2017.
Artigo em Chinês | WPRIM | ID: wpr-661069
ABSTRACT

OBJECTIVE:

To compare therapeutic efficacy and safety of chlorquinaldol-promestriene and miconazole nitrate for simple vulvovaginal candidiasis (VCC).

METHODS:

In retrospective analysis,a total of 231 patients with simple VCC were divided into observation group (116 cases) and control group (115 cases).Observation group was given Chlorquinaldol-promestriene vaginal tablet (0.2 g) every night.Control group was given Miconazole nitrate suppositories (200 mg) every night.Both groups received a course of treatment,lasting for 7 d.Clinical efficacies of 2 groups were observed at the first and second recheck.The symptom relief time recurrence and ADR of effective patients were observed.

RESULTS:

There was no statistical significance in the total response rates of 2 groups at the first reexamination,as well as total response rates of 2 groups and symptom relief time of effective patients at the second reexamination(P>0.05).At the second reexamination,reoccurrence rate of observation group was significantly lower than that of control group,with statistical significance (P<0.05).There was no statistical significance in the incidence of ADR between 2 groups(P>0.05).

CONCLUSIONS:

Chlorquinaldol-promestriene is similar to miconazole nitrate for VCC in therapeutic efficacy and safety,but chlorquinaldol-promestriene is better than miconazole nitrate in reducing recurrence rate.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: China Pharmacy Ano de publicação: 2017 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: China Pharmacy Ano de publicação: 2017 Tipo de documento: Artigo